1. Biology

TeraNet captures laser signals from German satellite, paving the way for 1,000-fold faster communication speeds from space

Written by Posted on Less than 0 min read

TeraNet3_18.jpg

Credit: Credit: ICRAR

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Agriculture accelerated human genome evolution to capture energy from starchy foods

Over the past 12,000 years, humans in Europe have dramatically increased their ability to digest carbohydrates, expanding the number of genes they have for enzymes that break down starch from an average of eight to more than 11, according to a new study by researchers from the U.S., Italy and United Kingdom. The rise in […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Avian flu found in wastewater of 10 Texas cities through virome sequencing

Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine. The virome is the collection of viruses in a sample, in this case a wastewater sample. The information was […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

12 new Oriental weevil species discovered using advanced imaging tools

Jake Lewis, an entomologist in the Environmental Science and Informatics Section at the Okinawa Institute of Science and Technology (OIST), is fascinated by weevils, a diverse group of beetles that includes many species with elephant trunk-like mouthparts (called a rostrum). Weevils provide various ecosystem services such as pollination and decomposition, but some species are serious […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Hijacking the command center of the cell: Nuclear parasites in deep-sea mussels

Most animals live in intimate relationships with bacteria. Some of these bacteria live inside the cells of their hosts, but only very few are able to live inside cell organelles (structures inside the cell, like organs in the body). One group of bacteria have figured out how to colonize the nuclei of their hosts, a […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Built-in dataset allows genes-to-ecosystems analysis

A primary-ever dataset bridging molecular details about the poplar tree microbiome to ecosystem-level processes has been launched by a workforce of Division of Vitality scientists led by Oak Ridge Nationwide Laboratory. The mission goals to tell analysis concerning how pure methods perform, their vulnerability to a altering local weather, and finally how crops may be […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Editing without ‘cutting’: Molecular mechanisms of new gene-editing tool revealed

Joint research led by Yutaro Shuto, Ryoya Nakagawa, and Osamu Nureki of the University of Tokyo determined the spatial structure of various processes of a novel gene-editing tool called “prime editor.” Functional analysis based on these structures also revealed how a “prime editor” could achieve reverse transcription, synthesizing DNA from RNA, without “cutting” both strands […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Elephants on the move: Mapping connections across African landscapes

Elephant conservation is a major priority in southern Africa, but habitat loss and urbanization mean the far-ranging pachyderms are increasingly restricted to protected areas like game reserves. The risk? Contained populations could become genetically isolated over time, making elephants more vulnerable to disease and environmental change. A recent study from the University of Illinois Urbana-Champaign […]
Written by
  1. Biology

Visual explanations of machine learning models to estimate charge states in

A group of researchers has successfully demonstrated automatic charge state recognition in quantum dot devices using machine learning techniques, representing a significant step towards automating the preparation and tuning of quantum bits (qubits) for quantum information processing. Credit: Yui Muto et al. A group of researchers has successfully demonstrated automatic charge state recognition in quantum […]
Written by
  1. Biology

Researchers from Tel Aviv University have for the first time created a

Researchers from Tel Aviv University (TAU) have created a new type of glass with unique and even contradictory properties, such as being a strong adhesive (sticky) and incredibly transparent at the same time. The glass, which forms spontaneously when comes in contact with water at room temperature, could bring about a revolution in an array […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Phase 2 Spring Trial Of LHP588, Treatment For P. Gingivalis-positive Alzheimer’s Disease Proceeds

SAN FRANCISCO, Nov. 16, 2023. Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of Alzheimer’s and other diseases of aging, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for LHP588, the company’s next-generation gingipain inhibitor, for the treatment of P. gingivalis-positive […]
Written by
  1. Clinical

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap

LEXINGTON, Mass.–(BUSINESS WIRE)–Aug. 8, 2024– Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the achievement of the primary endpoint in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial of 0.25% reproxalap ophthalmic solution, an investigational […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

First Person With Cystic Fibrosis Dosed In Phase 1 Trial Of Investigational Therapy Cm001, Designed To Form Ion Channels To Help Restore Airway Function

CHAMPAIGN, Ill., Oct. 30, 2023. cystetic Medicines, Inc., a clinical-stage biotechnology company developing small molecule channels that serve as molecular prosthetics for missing or dysfunctional CFTR protein channels, announced today it has dosed the first person with cystic fibrosis (CF) as part of an ongoing Phase 1 clinical trial (NCT05802264) of its investigational inhalable small […]
Written by
  1. Clinical

Repurposed Drug Fenoprofen Exhibits Promise Towards Endometriosis-Associated Ache in Animal Mannequin

March 18, 2024 — Fenoprofen, a nonsteroidal anti-inflammatory drug (NSAID), efficiently alleviated ache and irritation in a rodent mannequin of endometriosis, in response to researchers funded by the Nationwide Institutes of Well being (NIH). They selected the drug after utilizing a pc algorithm to guage practically 1,300 current compounds for his or her skill to […]
Written by
  1. Clinical

Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV

HAYWARD, Calif., May 30, 2024. Avirmax Biopharma, Inc., a leading innovator in genetic medicines, is pleased to announce that it has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration (AMD) including Polypoidal […]
Written by
  1. Clinical

Amylyx Prescribed drugs Publicizes Interim Information From Ongoing Part 2 HELIOS Scientific Trial Demonstrating Enhancements in Pancreatic Operate and Glycemic Management with AMX0035 in Individuals with Wolfram Syndrome

CAMBRIDGE, Mass.–(BUSINESS WIRE) April 10, 2024 — Amylyx Prescribed drugs, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Firm”) immediately introduced interim information from the continued Part 2 HELIOS scientific trial of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO, also known as ursodoxicoltaurine]) in adults dwelling with Wolfram syndrome, a uncommon, progressive genetic illness impacting roughly 3,000 […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus Saint-Herblain (France), November 10, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved Ixchiq®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

May 20, 2024 — The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept products work by inhibiting vascular endothelial growth factor (VEGF) which prevents abnormal blood vessel growth within the eye. By blocking VEGF, aflibercept products can slow down or reduce damage to the retina and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Supernus Gives Regulatory Replace for SPN-830

Generic identify: apomorphineTherapy for: Hypomobility in Parkinson’s Illness Supernus Gives Regulatory Replace for SPN-830 ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) — Supernus Prescription drugs, Inc. (Nasdaq: SUPN), a biopharmaceutical firm targeted on creating and commercializing merchandise for the remedy of central nervous system (CNS) illnesses, right now introduced a regulatory replace for SPN-830. SPN-830 […]
Written by
  1. Nonclinical

Diversifying your skill set: The rising trend of nonclinical careers for physicians

Title: Diversifying Your Skill Set: The Rising Trend of Nonclinical Careers for Physicians Introduction: The medical profession has long been associated with clinical practice, with doctors predominantly working in hospitals, clinics, or private practices. However, an increasing number of physicians are now venturing into nonclinical career paths, showcasing their diverse skill sets and contributing their […]
Written by
  1. Nonclinical

From the clinic to the boardroom: Thriving in nonclinical career options for physicians

Title: From the Clinic to the Boardroom: Thriving in Nonclinical Career Options for Physicians Introduction: For many physicians, the path from medical school to clinical practice has been the traditional route. However, with the evolving healthcare landscape and the growing demand for healthcare leaders in nontraditional settings, an increasing number of doctors are embracing nonclinical […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: TeraNet captures laser signals from German satellite, paving the way for 1,000-fold faster communication speeds from space

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.